Skip to main content
Top
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO)

Authors: Javier A Menendez, Alejandro Vazquez-Martin, Rocio Garcia-Villalba, Alegria Carrasco-Pancorbo, Cristina Oliveras-Ferraros, Alberto Fernandez-Gutierrez, Antonio Segura-Carretero

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

The effects of the olive oil-rich Mediterranean diet on breast cancer risk might be underestimated when HER2 (ERBB2) oncogene-positive and HER2-negative breast carcinomas are considered together. We here investigated the anti-HER2 effects of phenolic fractions directly extracted from Extra Virgin Olive Oil (EVOO) in cultured human breast cancer cell lines.

Methods

Solid phase extraction followed by semi-preparative high-performance liquid chromatography (HPLC) was used to isolate phenolic fractions from commercial EVOO. Analytical capillary electrophoresis coupled to mass spectrometry was performed to check for the composition and to confirm the identity of the isolated fractions. EVOO polyphenolic fractions were tested on their tumoricidal ability against HER2-negative and HER2-positive breast cancer in vitro models using MTT, crystal violet staining, and Cell Death ELISA assays. The effects of EVOO polyphenolic fractions on the expression and activation status of HER2 oncoprotein were evaluated using HER2-specific ELISAs and immunoblotting procedures, respectively.

Results

Among the fractions mainly containing the single phenols hydroxytyrosol and tyrosol, the polyphenol acid elenolic acid, the lignans (+)-pinoresinol and 1-(+)-acetoxypinoresinol, and the secoiridoids deacetoxy oleuropein aglycone, ligstroside aglycone, and oleuropein aglycone, all the major EVOO polyphenols (i.e. secoiridoids and lignans) were found to induce strong tumoricidal effects within a micromolar range by selectively triggering high levels of apoptotic cell death in HER2-overexpressors. Small interfering RNA-induced depletion of HER2 protein and lapatinib-induced blockade of HER2 tyrosine kinase activity both significantly prevented EVOO polyphenols-induced cytotoxicity. EVOO polyphenols drastically depleted HER2 protein and reduced HER2 tyrosine autophosphorylation in a dose- and time-dependent manner. EVOO polyphenols-induced HER2 downregulation occurred regardless the molecular mechanism contributing to HER2 overexpression (i.e. naturally by gene amplification and ectopically driven by a viral promoter). Pre-treatment with the proteasome inhibitor MG132 prevented EVOO polyphenols-induced HER2 depletion.

Conclusion

The ability of EVOO-derived polyphenols to inhibit HER2 activity by promoting the proteasomal degradation of the HER2 protein itself, together with the fact that humans have safely been ingesting secoiridoids and lignans as long as they have been consuming olives and OO, support the notion that the stereochemistry of these phytochemicals might provide an excellent and safe platform for the design of new HER2-targeting agents.
Appendix
Available only for authorised users
Literature
1.
go back to reference Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D: Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 2000, 9: 869-873.PubMed Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D: Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 2000, 9: 869-873.PubMed
2.
go back to reference Simopoulos P: : What is so special about the diet of Greece? The scientific evidence. J Nutr. 2001, 131 (11 Suppl): 3065S-3073S.PubMed Simopoulos P: : What is so special about the diet of Greece? The scientific evidence. J Nutr. 2001, 131 (11 Suppl): 3065S-3073S.PubMed
3.
4.
go back to reference Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, Barja G, Battino M, Blanco A, Bonanome A, Colomer R, Corella-Piquer D, et al: International conference on the healthy effect of virgin olive oil. Eur J Clin Invest. 2005, 35: 421-424.CrossRefPubMed Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, Barja G, Battino M, Blanco A, Bonanome A, Colomer R, Corella-Piquer D, et al: International conference on the healthy effect of virgin olive oil. Eur J Clin Invest. 2005, 35: 421-424.CrossRefPubMed
5.
go back to reference Colomer R, Menendez JA: Mediterranean diet, olive oil and cancer. Clin Transl Oncol. 2006, 8: 15-21.CrossRefPubMed Colomer R, Menendez JA: Mediterranean diet, olive oil and cancer. Clin Transl Oncol. 2006, 8: 15-21.CrossRefPubMed
6.
go back to reference Sant M, Allemani C, Sieri S, Krogh V, Menard S, Tagliabue E, Nardini E, Micheli A, Crosignani P, Muti P, Berrino F: Salad vegetables dietary pattern protects against HER-2-positive breast cancer: A prospective Italian study. Int J Cancer. 2007, 121: 911-914.CrossRefPubMed Sant M, Allemani C, Sieri S, Krogh V, Menard S, Tagliabue E, Nardini E, Micheli A, Crosignani P, Muti P, Berrino F: Salad vegetables dietary pattern protects against HER-2-positive breast cancer: A prospective Italian study. Int J Cancer. 2007, 121: 911-914.CrossRefPubMed
7.
go back to reference Sieri S, Krogh V, Pala V, Muti P, Micheli A, Evangelista A, Tagliabue G, Berrino F: Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev. 2004, 13: 567-572.PubMed Sieri S, Krogh V, Pala V, Muti P, Micheli A, Evangelista A, Tagliabue G, Berrino F: Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev. 2004, 13: 567-572.PubMed
8.
go back to reference Harari D, Yarden Y: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. 2000, 19: 6102-6114.CrossRefPubMed Harari D, Yarden Y: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. 2000, 19: 6102-6114.CrossRefPubMed
9.
10.
go back to reference Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001, 2: 127-137.CrossRefPubMed Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001, 2: 127-137.CrossRefPubMed
11.
go back to reference Hynes NE, Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005, 5: 341-354.CrossRefPubMed Hynes NE, Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005, 5: 341-354.CrossRefPubMed
12.
go back to reference Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ: Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol. 2006, 3: 269-280.CrossRefPubMed Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ: Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol. 2006, 3: 269-280.CrossRefPubMed
13.
go back to reference Solanas M, Hurtado A, Costa I, Moral R, Menendez JA, Colomer R, Escrich E: Effects of a high olive oil diet on the clinical behavior and histopathological features of rat DMBA-induced mammary tumors compared with a high corn oil diet. Int J Oncol. 2002, 21: 745-753.PubMed Solanas M, Hurtado A, Costa I, Moral R, Menendez JA, Colomer R, Escrich E: Effects of a high olive oil diet on the clinical behavior and histopathological features of rat DMBA-induced mammary tumors compared with a high corn oil diet. Int J Oncol. 2002, 21: 745-753.PubMed
14.
go back to reference Moral R, Solanas M, Garcia G, Colomer R, Escrich E: Modulation of EGFR and neu expression by n-6 and n-9 high-fat diets in experimental mammary adenocarcinomas. Oncol Rep. 2003, 10: 1417-1424.PubMed Moral R, Solanas M, Garcia G, Colomer R, Escrich E: Modulation of EGFR and neu expression by n-6 and n-9 high-fat diets in experimental mammary adenocarcinomas. Oncol Rep. 2003, 10: 1417-1424.PubMed
15.
go back to reference Menendez JA, Ropero S, Lupu R, Colomer R: Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells. Ann Oncol. 2004, 15: 1719-1721.CrossRefPubMed Menendez JA, Ropero S, Lupu R, Colomer R: Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells. Ann Oncol. 2004, 15: 1719-1721.CrossRefPubMed
16.
go back to reference Menendez JA, Vellon L, Colomer R, Lupu R: Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005, 16: 359-371.CrossRefPubMed Menendez JA, Vellon L, Colomer R, Lupu R: Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005, 16: 359-371.CrossRefPubMed
17.
18.
go back to reference Menendez JA, Papadimitropoulou A, Vellon L, Lupu R: A genomic explanation connecting "Mediterranean diet", olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur J Cancer. 2006, 42: 2425-2432.CrossRefPubMed Menendez JA, Papadimitropoulou A, Vellon L, Lupu R: A genomic explanation connecting "Mediterranean diet", olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. Eur J Cancer. 2006, 42: 2425-2432.CrossRefPubMed
19.
go back to reference Menendez JA, Lupu R: Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr Pharm Biotechnol. 2006, 7: 495-502.CrossRefPubMed Menendez JA, Lupu R: Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr Pharm Biotechnol. 2006, 7: 495-502.CrossRefPubMed
20.
go back to reference Menendez JA, Vazquez-Martin A, Colomer R, Brunet J, Carrasco-Pancorbo A, Garcia-Villalba R, Fernandez-Gutierrez A, Segura-Carretero A: Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer. 2007, 7: 80-CrossRefPubMedPubMedCentral Menendez JA, Vazquez-Martin A, Colomer R, Brunet J, Carrasco-Pancorbo A, Garcia-Villalba R, Fernandez-Gutierrez A, Segura-Carretero A: Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer. 2007, 7: 80-CrossRefPubMedPubMedCentral
21.
go back to reference Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, Bartsch H: The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer. 2000, 36: 1235-1247.CrossRefPubMed Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, Bartsch H: The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer. 2000, 36: 1235-1247.CrossRefPubMed
22.
go back to reference Visioli F, Galli C: Olive oil: more than just oleic acid. Am J Clin Nutr. 2000, 72: 853-PubMed Visioli F, Galli C: Olive oil: more than just oleic acid. Am J Clin Nutr. 2000, 72: 853-PubMed
23.
go back to reference Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, Lee CH, Smith AB, Breslin PA: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005, 437: 45-46.CrossRefPubMed Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, Lee CH, Smith AB, Breslin PA: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005, 437: 45-46.CrossRefPubMed
24.
go back to reference Fogliano V, Sacchi R: Oleocanthal in olive oil: between myth and reality. Mol Nutr Food Res. 2006, 50: 5-6.CrossRefPubMed Fogliano V, Sacchi R: Oleocanthal in olive oil: between myth and reality. Mol Nutr Food Res. 2006, 50: 5-6.CrossRefPubMed
25.
go back to reference Galli C, Visioli F: Antioxidant and other activities of phenolics in olives/olive oil, typical components of the Mediterranean diet. Lipids. 1999, 34 (Suppl): S23-S26.CrossRefPubMed Galli C, Visioli F: Antioxidant and other activities of phenolics in olives/olive oil, typical components of the Mediterranean diet. Lipids. 1999, 34 (Suppl): S23-S26.CrossRefPubMed
26.
go back to reference Visioli F, Poli A, Gall C: Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev. 2002, 22: 65-75.CrossRefPubMed Visioli F, Poli A, Gall C: Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev. 2002, 22: 65-75.CrossRefPubMed
27.
go back to reference Visioli F, Galli C: Phenolics from olive oil and its waste products. Biological activities in in vitro and in vivo studies. World Rev Nutr Diet. 2001, 88: 233-237.CrossRefPubMed Visioli F, Galli C: Phenolics from olive oil and its waste products. Biological activities in in vitro and in vivo studies. World Rev Nutr Diet. 2001, 88: 233-237.CrossRefPubMed
28.
go back to reference Visioli F, Galli C: Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr. 2002, 42: 209-221.CrossRefPubMed Visioli F, Galli C: Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr. 2002, 42: 209-221.CrossRefPubMed
29.
go back to reference Hashim YZ, Eng M, Gill CI, McGlynn H, Rowland IR: Components of olive oil and chemoprevention of colorectal cancer. Nutr Rev. 2005, 63: 374-386.CrossRefPubMed Hashim YZ, Eng M, Gill CI, McGlynn H, Rowland IR: Components of olive oil and chemoprevention of colorectal cancer. Nutr Rev. 2005, 63: 374-386.CrossRefPubMed
30.
go back to reference Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H: Identification of lignans as major components in the phenolic fraction of olive oil. Clin Chem. 2000, 46: 976-988.PubMed Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H: Identification of lignans as major components in the phenolic fraction of olive oil. Clin Chem. 2000, 46: 976-988.PubMed
31.
go back to reference Buiarelli F, Di Berardino S, Coccioli F, Jasionowska R, Russo MV: Determination of phenolic acids in olive oil by capillary electrophoresis. Ann Chim. 2004, 94: 699-705.CrossRefPubMed Buiarelli F, Di Berardino S, Coccioli F, Jasionowska R, Russo MV: Determination of phenolic acids in olive oil by capillary electrophoresis. Ann Chim. 2004, 94: 699-705.CrossRefPubMed
32.
go back to reference Carrasco Pancorbo A, Cruces-Blanco C, Segura Carretero A, Fernandez Gutierrez A: Sensitive determination of phenolic acids in extra-virgin olive oil by capillary zone electrophoresis. J Agric Food Chem. 2004, 52: 6687-93.CrossRefPubMed Carrasco Pancorbo A, Cruces-Blanco C, Segura Carretero A, Fernandez Gutierrez A: Sensitive determination of phenolic acids in extra-virgin olive oil by capillary zone electrophoresis. J Agric Food Chem. 2004, 52: 6687-93.CrossRefPubMed
33.
go back to reference Lavelli V, Bondesan L: Secoiridoids, tocopherols, and antioxidant activity of monovarietal extra virgin olive oils extracted from destoned fruits. J Agric Food Chem. 2005, 53: 1102-1107.CrossRefPubMed Lavelli V, Bondesan L: Secoiridoids, tocopherols, and antioxidant activity of monovarietal extra virgin olive oils extracted from destoned fruits. J Agric Food Chem. 2005, 53: 1102-1107.CrossRefPubMed
34.
go back to reference Gomez Caravaca AM, Carrasco Pancorbo A, Canabate Diaz B, Segura Carretero A, Fernandez Gutierrez A: Electrophoretic identification and quantitation of compounds in the polyphenolic fraction of extra-virgin olive oil. Electrophoresis. 2005, 26: 3538-3551.CrossRefPubMed Gomez Caravaca AM, Carrasco Pancorbo A, Canabate Diaz B, Segura Carretero A, Fernandez Gutierrez A: Electrophoretic identification and quantitation of compounds in the polyphenolic fraction of extra-virgin olive oil. Electrophoresis. 2005, 26: 3538-3551.CrossRefPubMed
35.
go back to reference Carrasco-Pancorbo A, Arraez-Roman D, Segura-Carretero A, Fernandez-Gutierrez A: Capillary electrophoresis-electrospray ionization-mass spectrometry method to determine the phenolic fraction of extra-virgin olive oil. Electrophoresis. 2006, 27: 2182-2196.CrossRefPubMed Carrasco-Pancorbo A, Arraez-Roman D, Segura-Carretero A, Fernandez-Gutierrez A: Capillary electrophoresis-electrospray ionization-mass spectrometry method to determine the phenolic fraction of extra-virgin olive oil. Electrophoresis. 2006, 27: 2182-2196.CrossRefPubMed
36.
go back to reference Carrasco-Pancorbo A, Gomez-Caravaca AM, Cerretani L, Bendini A, Segura-Carretero A, Fernandez-Gutierrez A: Rapid quantification of the phenolic fraction of Spanish virgin olive oils by capillary electrophoresis with UV detection. J Agric Food Chem. 2006, 54: 7984-7991.CrossRefPubMed Carrasco-Pancorbo A, Gomez-Caravaca AM, Cerretani L, Bendini A, Segura-Carretero A, Fernandez-Gutierrez A: Rapid quantification of the phenolic fraction of Spanish virgin olive oils by capillary electrophoresis with UV detection. J Agric Food Chem. 2006, 54: 7984-7991.CrossRefPubMed
37.
go back to reference Carrasco-Pancorbo A, Neususs C, Pelzing M, Segura-Carretero A, Fernandez-Gutierrez A: CE- and HPLC-TOF-MS for the characterization of phenolic compounds in olive oil. Electrophoresis. 2007, 28: 806-821.CrossRefPubMed Carrasco-Pancorbo A, Neususs C, Pelzing M, Segura-Carretero A, Fernandez-Gutierrez A: CE- and HPLC-TOF-MS for the characterization of phenolic compounds in olive oil. Electrophoresis. 2007, 28: 806-821.CrossRefPubMed
38.
go back to reference Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL: Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Cancer Res. 2002, 62: 4132-4141.PubMed Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL: Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Cancer Res. 2002, 62: 4132-4141.PubMed
39.
go back to reference Diermeier S, Horvath G, Knuechel-Clarke R, Hofstaedter F, Szollosi J, Brockhoff G: Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp Cell Res. 2005, 304: 604-619.CrossRefPubMed Diermeier S, Horvath G, Knuechel-Clarke R, Hofstaedter F, Szollosi J, Brockhoff G: Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp Cell Res. 2005, 304: 604-619.CrossRefPubMed
40.
go back to reference Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM, Osborne CK: Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat. 1992, 24: 85-95.CrossRefPubMed Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM, Osborne CK: Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat. 1992, 24: 85-95.CrossRefPubMed
41.
go back to reference Way TD, Kao MC, Lin JK: Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem. 2004, 279: 4479-4489.CrossRefPubMed Way TD, Kao MC, Lin JK: Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem. 2004, 279: 4479-4489.CrossRefPubMed
42.
go back to reference Way TD, Kao MC, Lin JK: Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett. 2005, 579: 145-52.CrossRefPubMed Way TD, Kao MC, Lin JK: Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett. 2005, 579: 145-52.CrossRefPubMed
43.
go back to reference Chiang CT, Way TD, Lin JK: Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21WAF1/CIP1 expression with rapamycin. Mol Cancer Ther. 2007, 6: 2127-2138.CrossRefPubMed Chiang CT, Way TD, Lin JK: Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21WAF1/CIP1 expression with rapamycin. Mol Cancer Ther. 2007, 6: 2127-2138.CrossRefPubMed
44.
go back to reference Hollywood DP, Hurst HC: Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma. Br J Cancer. 1995, 71: 753-757.CrossRefPubMedPubMedCentral Hollywood DP, Hurst HC: Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma. Br J Cancer. 1995, 71: 753-757.CrossRefPubMedPubMedCentral
45.
go back to reference Hurst HC: Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res. 2001, 3: 395-398.CrossRefPubMedPubMedCentral Hurst HC: Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res. 2001, 3: 395-398.CrossRefPubMedPubMedCentral
46.
go back to reference Vissers MN, Zock PL, Roodenburg AJC, Leenen R, Katan MB: Olive oil phenols are absorbed in humans. J Nutr. 2002, 132: 409-417.PubMed Vissers MN, Zock PL, Roodenburg AJC, Leenen R, Katan MB: Olive oil phenols are absorbed in humans. J Nutr. 2002, 132: 409-417.PubMed
47.
go back to reference Visioli F, Galli C, Bornet F, Mattei A, Patelli R, Galli G, Caruso D: Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett. 2000, 468: 159-160.CrossRefPubMed Visioli F, Galli C, Bornet F, Mattei A, Patelli R, Galli G, Caruso D: Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett. 2000, 468: 159-160.CrossRefPubMed
48.
go back to reference Scalbert A, Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr. 2000, 130: 2073S-2085S.PubMed Scalbert A, Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr. 2000, 130: 2073S-2085S.PubMed
49.
go back to reference Vissers MN, Zock PL, Roodenburg AJC, Leenen R, Katan MB: Olive oil phenols are absorbed in humans. J Nutr. 2002, 132: 409-417.PubMed Vissers MN, Zock PL, Roodenburg AJC, Leenen R, Katan MB: Olive oil phenols are absorbed in humans. J Nutr. 2002, 132: 409-417.PubMed
50.
go back to reference Paganga G, RiceEvans CA: The identification of flavonoids as glycosides in human plasma. FEBS Lett. 1997, 401: 78-82.CrossRefPubMed Paganga G, RiceEvans CA: The identification of flavonoids as glycosides in human plasma. FEBS Lett. 1997, 401: 78-82.CrossRefPubMed
51.
go back to reference Saarinen NM, Power KA, Chen J, Thompson LU: Lignans are accessible to human breast cancer xenografts in athymic mice. Nutr Cancer. 2008, 60: 245-250.CrossRefPubMed Saarinen NM, Power KA, Chen J, Thompson LU: Lignans are accessible to human breast cancer xenografts in athymic mice. Nutr Cancer. 2008, 60: 245-250.CrossRefPubMed
52.
go back to reference Thompson LU, Chen JM, Strasser-Weippl K, Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005, 11: 3828-3835.CrossRefPubMed Thompson LU, Chen JM, Strasser-Weippl K, Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005, 11: 3828-3835.CrossRefPubMed
Metadata
Title
tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO)
Authors
Javier A Menendez
Alejandro Vazquez-Martin
Rocio Garcia-Villalba
Alegria Carrasco-Pancorbo
Cristina Oliveras-Ferraros
Alberto Fernandez-Gutierrez
Antonio Segura-Carretero
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-377

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine